GB1405767A - Method formulation and pharmaceutical composition for reducing plasma lipid levels - Google Patents
Method formulation and pharmaceutical composition for reducing plasma lipid levelsInfo
- Publication number
- GB1405767A GB1405767A GB5783072A GB5783072A GB1405767A GB 1405767 A GB1405767 A GB 1405767A GB 5783072 A GB5783072 A GB 5783072A GB 5783072 A GB5783072 A GB 5783072A GB 1405767 A GB1405767 A GB 1405767A
- Authority
- GB
- United Kingdom
- Prior art keywords
- group
- plasma lipid
- lipid levels
- pharmaceutical composition
- reducing plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
1405767 Plasma lipid-reducing medicines ETHYL CORP 14 Dec 1972 57830/72 Heading A5B Compositions for reducing plasma lipid levels comprise a carrier and a compound: wherein each R is the same or different and is an alkyl, cycloalkyl, aryl or aralkyl group, R 1 and R 2 . are each hydrogen or a group as defined for R or they form, together with the C atom a C=S group, R 3 and R 4 are each hydro-. gen or a group as defined for R or, together with the N atom, they form a pyridine, piperidine, piperazine or morpholine group, "a" is from 0 to 4 and "b" and "e" are the same or different and are each 0 or 1. The compositions may be in conventional forms for oral and parenteral administration and may contain the usual carriers and excipients. The active compounds may be used in the form of salts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5783072A GB1405767A (en) | 1972-12-14 | 1972-12-14 | Method formulation and pharmaceutical composition for reducing plasma lipid levels |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5783072A GB1405767A (en) | 1972-12-14 | 1972-12-14 | Method formulation and pharmaceutical composition for reducing plasma lipid levels |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1405767A true GB1405767A (en) | 1975-09-10 |
Family
ID=10480127
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5783072A Expired GB1405767A (en) | 1972-12-14 | 1972-12-14 | Method formulation and pharmaceutical composition for reducing plasma lipid levels |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1405767A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4173652A (en) * | 1976-12-18 | 1979-11-06 | Akzona Incorporated | Pharmaceutical hydroxamic acid compositions and uses thereof |
US4448776A (en) * | 1981-02-12 | 1984-05-15 | Karl Bucher | Method of using certain substituted aliphatic secondary amines or their salts for easing breathing |
EP0404039A1 (en) * | 1989-06-23 | 1990-12-27 | Roche Diagnostics GmbH | Pharmaceuticals containing di-tert.butylhydroxyphenyl-derivatives and new derivatives |
EP0476846A2 (en) * | 1990-08-27 | 1992-03-25 | Eli Lilly And Company | Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy |
US5280046A (en) * | 1991-02-22 | 1994-01-18 | The University Of Colorado Foundation, Inc. | Method of treating type I diabetes |
US5552439A (en) * | 1990-08-27 | 1996-09-03 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
-
1972
- 1972-12-14 GB GB5783072A patent/GB1405767A/en not_active Expired
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4173652A (en) * | 1976-12-18 | 1979-11-06 | Akzona Incorporated | Pharmaceutical hydroxamic acid compositions and uses thereof |
US4448776A (en) * | 1981-02-12 | 1984-05-15 | Karl Bucher | Method of using certain substituted aliphatic secondary amines or their salts for easing breathing |
EP0404039A1 (en) * | 1989-06-23 | 1990-12-27 | Roche Diagnostics GmbH | Pharmaceuticals containing di-tert.butylhydroxyphenyl-derivatives and new derivatives |
EP0476846A2 (en) * | 1990-08-27 | 1992-03-25 | Eli Lilly And Company | Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy |
EP0476846A3 (en) * | 1990-08-27 | 1992-08-05 | Eli Lilly And Company | Method for treating imflammation, ischemia-induced cell damage and muscular dystrophy |
US5281623A (en) * | 1990-08-27 | 1994-01-25 | Eli Lilly And Company | Method for treating inflammation |
US5393786A (en) * | 1990-08-27 | 1995-02-28 | Eli Lilly And Company | Method for treating inflammation, ischemia-induced cell damage and muscular dystrophy |
US5552439A (en) * | 1990-08-27 | 1996-09-03 | Eli Lilly And Company | Method of treating inflammatory bowel disease |
US5280046A (en) * | 1991-02-22 | 1994-01-18 | The University Of Colorado Foundation, Inc. | Method of treating type I diabetes |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1505305A (en) | Benzcycloamide derivatives | |
GB1205957A (en) | Pharmaceutical compositions comprising 1-pnenoxy-2-aminopropanes | |
GB1260848A (en) | Propanolamine derivatives | |
GB1181673A (en) | Derivatives of Xanthen and Thiaxanthen and Preparation Thereof | |
GB1405767A (en) | Method formulation and pharmaceutical composition for reducing plasma lipid levels | |
GB1420411A (en) | Pyridine compounds and process for their manufacture | |
NO175979C (en) | Analogous Process for Preparation of Therapeutically Active Pteridines | |
GB1342520A (en) | Alpha-alkyl-substituted benzyl or thenyl-benzyloxy derivatives of amines | |
GB1296544A (en) | ||
GB1444396A (en) | Succinic acid derivatives | |
GB1084150A (en) | ||
GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
GB1530138A (en) | Pharmaceutical composition | |
GB1246117A (en) | Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture | |
GB1514225A (en) | Paracetamol derivatives | |
GB1424432A (en) | Pharmaceutical compositions | |
GB1156781A (en) | New Heterocyclic Compounds | |
GB1492622A (en) | Aralkyl esters of amino alkanoic acids | |
GB1120186A (en) | Cyclohexene amino acid derivatives and process for their preparation | |
ES8200347A1 (en) | Pyridine derivatives, process for their preparation and medicaments containing them. | |
GB1423761A (en) | Xylidides | |
GB1322640A (en) | Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon | |
GB1448758A (en) | Thiazole derivatives | |
GB1469430A (en) | Daunomycin derivatives | |
ES345994A1 (en) | 2-(di - (beta-hydroxy-lower alkyl)amino)-4,7-di - (heterocyclic amino) - 6 - phenyl-pteridines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |